Jenny G Low Selected Research

celgosivir

3/2016	Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy.
8/2014	Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jenny G Low Research Topics

Disease

8	Infections 01/2021 - 01/2011
7	Dengue (Dengue Fever) 01/2021 - 01/2011
5	Fever (Fevers) 01/2020 - 01/2011
3	Yellow Fever 01/2020 - 04/2015
3	Viremia 01/2020 - 03/2016
2	Diarrhea 01/2022 - 01/2020
2	Mosquito-Borne Diseases 11/2021 - 08/2014
2	COVID-19 11/2021 - 01/2021
2	Inflammation (Inflammations) 06/2021 - 01/2021
2	Disease Progression 03/2021 - 01/2020
2	Hemorrhage 11/2020 - 01/2017
2	Thrombocytopenia (Thrombopenia) 11/2020 - 01/2017
2	Rabies (Hydrophobia) 12/2017 - 01/2017
1	Fatigue 01/2022
1	Measles 11/2021
1	Acute Disease 11/2021
1	Abscess 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Liver Abscess 01/2020
1	Nausea 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Vomiting 01/2020
1	Pain (Aches) 01/2017
1	Japanese Encephalitis 04/2015
1	Coinfection 01/2011

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 11/2021 - 04/2015
4	Antiviral Agents (Antivirals)IBA 01/2020 - 08/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2021 - 04/2015
2	Neutralizing AntibodiesIBA 01/2021 - 01/2011
2	Rabies Vaccines (Rabies Vaccine)FDA Link 12/2017 - 01/2017
2	celgosivirIBA 03/2016 - 08/2014
1	SolutionsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Explosive Agents (Explosives)IBA 11/2021
1	mRNA VaccinesIBA 11/2021
1	AllergensIBA 06/2021
1	Interferon Type IIBA 03/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	CytokinesIBA 01/2021
1	Lopinavir FDA Link 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 01/2020
1	TY014IBA 01/2020
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	Attenuated VaccinesIBA 10/2017
1	GlucosidasesIBA 08/2014
1	Immunoglobulin G (IgG)IBA 01/2011

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 11/2020 - 01/2017
1	Critical Care (Surgical Intensive Care) 01/2020
1	Fluid Therapy (Oral Rehydration Therapy) 01/2017
1	Bed Rest (Bedrest) 01/2017